April 24, 2023, Montréal, Canada – Long before the COVID-19 pandemic, Vantage BioTrials had established the need to virtualize and offer its employees flexibility by offering remote working conditions. As a niche CRO, we believe in making a difference by striving to find better ways to reduce our carbon footprint, be productive and more efficient. By going virtual, we are achieving the following benefits:   Reducing Waste and Carbon Footprint: We have digitized all SOPs and Policies and...

July 18, 2022, Montréal, Canada – Vantage BioTrials, a full-service Contract Research Organization (CRO), has on-boarded a robust technology solution to manage its growing demand of early/late phase and medical device clinical trials. Accuracy, flexibility, and speed in obtaining real-time data are crucial. During the last couple of years of the Covid-19 pandemic, Vantage BioTrials remained focused in identifying areas of development that will add value to the overall maintenance, tracking a...

August 30, 2021, Montréal, Canada – Vantage BioTrials, a full service Contract Research Organization (CRO), is proud to have successfully managed, and completed approximately 12 months in advance, a Phase IV observational, multicentre, postmarketing study in adult patients with a clinical diagnosis of moderate-to-severe Hidradenitis suppurativa (HS). The primary objective of this clinical trial was to measure real-world effectiveness of adalimumab in HS and to secondarily observe clinical <...

August 27, 2020, Montréal, Canada – Vantage BioTrials, a full service Contract Research Organization (CRO), has partnered with its biotech Sponsor, Laurent Pharmaceuticals, to lead all clinical trial management activities of their lead oral drug candidate LAU-7b in a multicentric Phase 2 placebo-controlled clinical trial (RESOLUTION) in patients with COVID-19. We are pleased to join Laurent Pharmaceuticals in announcing that approval has been received from the Food and Drug Administration (FD...

MONTREAL, May 20, 2020 –Vantage BioTrials, a member of IMC, is a full-service Contract Research Organization (CRO) based in Canada that provides Phase I-IV clinical trial management services to pharmaceutical, biotechnology and medical device companies. Amid the on-going COVID-19 pandemic, our President, Vatche Bartekian, was interviewed by IMC about the current crisis and provided some insights on how Vantage BioTrials is overcoming some of the challenges caused by COVID-19. Below is the det...